Department of Molecular Immunology and Inflammation, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Department of Stem Cell Biology, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Proc Natl Acad Sci U S A. 2021 Aug 17;118(33). doi: 10.1073/pnas.2100295118.
The amino acid and oligopeptide transporter Solute carrier family 15 member A4 (SLC15A4), which resides in lysosomes and is preferentially expressed in immune cells, plays critical roles in the pathogenesis of lupus and colitis in murine models. Toll-like receptor (TLR)7/9- and nucleotide-binding oligomerization domain-containing protein 1 (NOD1)-mediated inflammatory responses require SLC15A4 function for regulating the mechanistic target of rapamycin complex 1 (mTORC1) or transporting L-Ala-γ-D-Glu-meso-diaminopimelic acid, IL-12: interleukin-12 (Tri-DAP), respectively. Here, we further investigated the mechanism of how SLC15A4 directs inflammatory responses. Proximity-dependent biotin identification revealed glycolysis as highly enriched gene ontology terms. Fluxome analyses in macrophages indicated that SLC15A4 loss causes insufficient biotransformation of pyruvate to the tricarboxylic acid cycle, while increasing glutaminolysis to the cycle. Furthermore, SLC15A4 was required for M1-prone metabolic change and inflammatory IL-12 cytokine productions after TLR9 stimulation. SLC15A4 could be in close proximity to AMP-activated protein kinase (AMPK) and mTOR, and SLC15A4 deficiency impaired TLR-mediated AMPK activation. Interestingly, SLC15A4-intact but not SLC15A4-deficient macrophages became resistant to fluctuations in environmental nutrient levels by limiting the use of the glutamine source; thus, SLC15A4 was critical for macrophage's respiratory homeostasis. Our findings reveal a mechanism of metabolic regulation in which an amino acid transporter acts as a gatekeeper that protects immune cells' ability to acquire an M1-prone metabolic phenotype in inflammatory tissues by mitigating metabolic stress.
溶质载体家族 15 成员 A4(SLC15A4)是一种氨基酸和寡肽转运蛋白,位于溶酶体中,在免疫细胞中优先表达,在狼疮和结肠炎的小鼠模型中发挥关键作用。Toll 样受体(TLR)7/9 和核苷酸结合寡聚化结构域包含蛋白 1(NOD1)介导的炎症反应需要 SLC15A4 功能来调节雷帕霉素靶蛋白复合物 1(mTORC1)或分别转运 L-Ala-γ-D-Glu-meso-二氨基庚二酸、白细胞介素-12(Tri-DAP)。在这里,我们进一步研究了 SLC15A4 指导炎症反应的机制。邻近依赖性生物素鉴定揭示了糖酵解是高度富集的基因本体术语。巨噬细胞中的通量分析表明,SLC15A4 缺失导致丙酮酸向三羧酸循环的生物转化不足,而增加向循环的谷氨酰胺分解。此外,SLC15A4 是 TLR9 刺激后 M1 倾向代谢变化和炎症性白细胞介素-12 细胞因子产生所必需的。SLC15A4 可以与 AMP 激活的蛋白激酶(AMPK)和 mTOR 接近,并且 SLC15A4 缺乏会损害 TLR 介导的 AMPK 激活。有趣的是,SLC15A4 完整但不是 SLC15A4 缺陷的巨噬细胞通过限制对谷氨酰胺来源的使用,对环境营养水平的波动变得具有抵抗力;因此,SLC15A4 对巨噬细胞的呼吸稳态至关重要。我们的发现揭示了一种代谢调节机制,其中氨基酸转运蛋白作为一种守门员,通过减轻代谢应激来保护免疫细胞在炎症组织中获得 M1 倾向代谢表型的能力。